Skip to main content
Clinical Trials/ChiCTR2200060259
ChiCTR2200060259CompletedEarly Phase 1

超声引导下腓肠肌阻滞的解剖研究

自筹1 site in 1 country5 target enrollmentStarted: December 24, 2021Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Completed
Sponsor
Enrollment
5
Locations
1
Primary Endpoint
神经染色程度

Study Overview

Brief Summary

于腓肠肌表面和下方注射美蓝溶剂,解剖研究美蓝对胫神经、腓总神经、腓肠外侧皮神经和腓肠内侧皮神经的染色效果

Study Design

Study Type
治疗研究
Primary Purpose
单臂

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 1.膝关节以上截肢等待焚烧下肢。

Exclusion Criteria

  • 1.下肢不完整,胫神经损伤、腓总神经损伤、腓肠内侧皮神经损伤、腓肠外侧皮神经损伤。

Arms & Interventions

干预组

美蓝染色

Outcomes

Primary Outcomes

神经染色程度

神经染色长度

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials